Bravado and complacency highlight the deep chinks in the country’s drug approval and safety processes that are still not good enough to stand global scrutiny.
At over 300,000 new infections and nearly 3,000 deaths a day, the second major wave of the COVID-19 pandemic has brought India to its knees. Heart-rending scenes play out outside hospitals in cities like Delhi and Mumbai every day as the healthcare system crumbles under the sheer weight of the galloping increase in cases. Beds, oxygen and life-saving drugs are all woefully short of demand. And there is no end in sight to the cycle of bad news.
Devi Shetty, noted cardiac surgeon and founder of Narayana Health, warns that things will get a lot worse in the coming months …
Surendar helps lead the newsroom at The Morning Context as executive editor. Over the years, Surendar has worked in industries from pharmaceuticals to diamonds, as well as a stint as an equity analyst. In his long career as a business journalist, he has led teams at The Times of India, India Today and Fortune India. He was part of the founding team at Forbes India and interned at and published in The Times, London.
Executive Editor
surendar@mailtmc.com
Mumbai